Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States

Leora R. Feldstein, Jasmine Ruffin, Ryan E. Wiegand, Jade James-Gist, Tara M. Babu, Craig B. Borkowf, Melissa Briggs-Hagen, James Chappell, Helen Y. Chu, Janet A. Englund, Jennifer L. Kuntz, Adam S. Lauring, Natalie Lo, Marco Carone, Christina Lockwood, Emily T. Martin, Claire M. Midgley, Arnold S. Monto, Allison L. Naleway, Tara Ogilvie, Sharon Saydah, Mark A. Schmidt, Jonathan E. Schmitz, Ning Smith, Ine Sohn, Lea Starita, H. Keipp Talbot, Ana A. Weil, Carlos G. Grijalva
doi: https://doi.org/10.1101/2024.11.01.24316597

Article Information

doi 
https://doi.org/10.1101/2024.11.01.24316597
History 
  • November 7, 2024.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.

Author Information

  1. Leora R. Feldstein, PhD1,*,
  2. Jasmine Ruffin, MPH1,
  3. Ryan E. Wiegand1,
  4. Jade James-Gist, MPH1,
  5. Tara M. Babu, MD2,
  6. Craig B. Borkowf, PhD1,
  7. Melissa Briggs-Hagen, MD1,
  8. James Chappell, MD, PhD3,
  9. Helen Y. Chu, MD2,
  10. Janet A. Englund, MD4,
  11. Jennifer L. Kuntz, PhD5,
  12. Adam S. Lauring, MD PhD6,
  13. Natalie Lo2,
  14. Marco Carone2,
  15. Christina Lockwood2,
  16. Emily T. Martin, PhD7,
  17. Claire M. Midgley, PhD1,
  18. Arnold S. Monto, MD7,
  19. Allison L. Naleway, PhD5,
  20. Tara Ogilvie2,
  21. Sharon Saydah, PhD1,
  22. Mark A. Schmidt, PhD5,
  23. Jonathan E. Schmitz, MD PhD3,
  24. Ning Smith, PhD5,
  25. Ine Sohn, MS3,
  26. Lea Starita2,
  27. H. Keipp Talbot, MD3,
  28. Ana A. Weil, MD2 and
  29. Carlos G. Grijalva, MD3
  1. 1Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
  2. 2Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA
  3. 3Vanderbilt University Medical Center, Nashville, Tennessee, USA
  4. 4Children’s Research Institute, Seattle, Washington, USA
  5. 5Kaiser Permanente Center for Health Research, Portland, Oregon, USA
  6. 6Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
  7. 7Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, Michigan, USA
  1. ↵*Corresponding author:
    Leora Feldstein, Centers for Disease Control and Prevention, Email: nqw5{at}cdc.gov
Back to top
Posted November 07, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Effectiveness of mRNA COVID-19 vaccines and hybrid immunity in preventing SARS-CoV-2 infection and symptomatic COVID-19 among adults in the United States
Leora R. Feldstein, Jasmine Ruffin, Ryan E. Wiegand, Jade James-Gist, Tara M. Babu, Craig B. Borkowf, Melissa Briggs-Hagen, James Chappell, Helen Y. Chu, Janet A. Englund, Jennifer L. Kuntz, Adam S. Lauring, Natalie Lo, Marco Carone, Christina Lockwood, Emily T. Martin, Claire M. Midgley, Arnold S. Monto, Allison L. Naleway, Tara Ogilvie, Sharon Saydah, Mark A. Schmidt, Jonathan E. Schmitz, Ning Smith, Ine Sohn, Lea Starita, H. Keipp Talbot, Ana A. Weil, Carlos G. Grijalva
medRxiv 2024.11.01.24316597; doi: https://doi.org/10.1101/2024.11.01.24316597
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area